A Dark Vector Cognition product

Item 2. PROPERTIES

2K characters. Original on sec.gov · Markdown

Item 2. PROPERTIES

AbbVie's corporate offices are located at 1 North Waukegan Road, North Chicago, Illinois 60064-6400. As of December 31, 2025, AbbVie owns or leases approximately 600 facilities worldwide, containing an aggregate of approximately 19.4 million square feet of floor space dedicated to production, distribution and administration. AbbVie's significant manufacturing sites are in the following locations:

United StatesOutside the United States
Abbott Park, Illinois*Campoverde di Aprilia, Italy
Barceloneta, Puerto RicoClonshaugh, Ireland
Branchburg, New Jersey*Cork, Ireland
Cincinnati, OhioLa Aurora, Costa Rica
Dublin, California*Ludwigshafen, Germany
Irvine, CaliforniaPringy, France
North Chicago, IllinoisSingapore*
Waco, TexasSligo, Ireland
Worcester, Massachusetts*Westport, Ireland*
Wyandotte, Michigan*

  • Leased property.

AbbVie believes its sites are suitable and provide adequate production capacity for its current and projected operations. There are no material encumbrances on AbbVie's owned properties.

AbbVie distributes products through a network of central and regional distribution centers, with its central distribution centers located in the U.S. and Europe. AbbVie also has research and development sites in the United States located at: Abbott Park, Illinois; Branchburg, New Jersey; Cambridge, Massachusetts; Irvine, California; Madison, New Jersey; Madison, Wisconsin; North Chicago, Illinois; Pleasanton, California; San Diego, California; South San Francisco, California; Waltham, Massachusetts, and Worcester, Massachusetts. Outside the United States, AbbVie's principal research and development facilities are located in Ludwigshafen, Germany and Oxford, United Kingdom.

Previous: Item 1C. CYBERSECURITY · Next: Item 3. LEGAL PROCEEDINGS